α-Glucosidase-IN-63 is a chemical compound identified by its CAS number 2375866-82-1, which indicates its unique molecular structure. This compound is primarily recognized for its role as an inhibitor of the enzyme α-glucosidase, which is involved in carbohydrate metabolism. By inhibiting this enzyme, α-Glucosidase-IN-63 can help regulate blood sugar levels, making it of interest in the treatment of conditions such as diabetes. The compound typically exhibits characteristics such as moderate solubility in organic solvents and potential bioactivity, which may be assessed through various pharmacological studies. Its molecular structure likely includes functional groups that contribute to its inhibitory action, and it may undergo metabolic transformations in biological systems. As with many pharmaceutical compounds, understanding its pharmacokinetics, efficacy, and safety profile is crucial for its application in therapeutic settings. Further research and clinical trials would be necessary to fully elucidate its potential benefits and limitations in medical use.

α-Glucosidase-IN-63

2375866-82-1: α-Glucosidase-IN-63 is a chemical compound identified by its CAS number 2375866-82-1, which indicates its unique molecular structure. This compound is primarily recognized for its role as an inhibitor of the enzyme α-glucosidase, which is involved in carbohydrate metabolism. By inhibiting this enzyme, α-Glucosidase-IN-63 can help regulate blood sugar levels, making it of interest in the treatment of conditions such as diabetes. The compound typically exhibits characteristics such as moderate solubility in organic solvents and potential bioactivity, which may be assessed through various pharmacological studies. Its molecular structure likely includes functional groups that contribute to its inhibitory action, and it may undergo metabolic transformations in biological systems. As with many pharmaceutical compounds, understanding its pharmacokinetics, efficacy, and safety profile is crucial for its application in therapeutic settings. Further research and clinical trials would be necessary to fully elucidate its potential benefits and limitations in medical use.

<p>α-Glucosidase-IN-63 (Compound 4d) serves as an α-Glucosidase inhibitor with an IC 50 value of 0.44 μM. Additionally, it exhibits inhibitory activity against hCA II, demonstrating a K i of 7.0 nM. The compound is also effective when administered orally. [1]</p>

CAS 2375866-82-1

α-Glucosidase-IN-63

α-Glucosidase-IN-63

Ref: TM-T87687